Cleared Traditional

K874618 - BAXTER ACCUPORT(TM) CENTRAL VENOUS CATHETER

K874618 is an FDA 510(k) clearance for BAXTER ACCUPORT(TM) CENTRAL VENOUS CATHETER, manufactured by Bentley Laboratories, Inc.. The device is a Class 2 Cardiovascular device with product code DQR cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K874618 · Bentley Laboratories, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1988
Decision
71d
Days
Class 2
Risk

K874618 is an FDA 510(k) clearance for the BAXTER ACCUPORT(TM) CENTRAL VENOUS CATHETER. Classified as Cannula, Catheter (product code DQR), Class II - Special Controls.

Submitted by Bentley Laboratories, Inc. (Irvine, US). The FDA issued a Cleared decision on January 19, 1988 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bentley Laboratories, Inc. devices

FDA 510(k) Submission Details - K874618

510(k) Number K874618 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 09, 1987
Decision Date January 19, 1988
Days to Decision 71 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 125d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQR Device Classification - Class 2, Special Controls

Product Code DQR Cannula, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQR Cannula, Catheter

All 18
Devices cleared under the same product code (DQR) and FDA review panel - the closest regulatory comparables to K874618.
TRANSLUMBAR AORTOGRAPHY NEEDLE CATHETER
K884375 · Argon Medical Corp. · Jan 1989
MEDSURG 7 FR. DUAL LUMEN CENTRAL VEIN CATH SYSTEM
K880771 · Medsurg Industries, Inc. · May 1988
7 FR. TRIPLE LUMEN CENTRAL VEIN CATHETERI. SYSTEM
K880776 · Medsurg Industries, Inc. · May 1988
TORAY ANTHRON ANGIOGRAPHIC CATHETERS
K872983 · Toray Industries (America), Inc. · Nov 1987
NEW MODEL STYLES FOR AORTIC ARCH CANNULA
K870825 · Shiley, Inc. · Mar 1987
ADDITIONAL LETTER DESIGNATION FOR AORTIC ARCH CAN.
K870826 · Shiley, Inc. · Mar 1987